CRYSTALLINE AND NON CRYSTALLINE FORMS OF SGLT2 INHIBITORS

CRYSTALLINE AND NON CRYSTALLINE FORMS OF SGLT2 INHIBITORS

The present invention provides amorphous forms and the crystalline complexes of SGLT2 inhibitors as a novel material in particular in pharmaceutically acceptable form. The crystalline forms of SGLT2 inhibitor canagliflozin are designated as Forms CS1 CS2 CS3 CS4 and CS5.

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: HENSCHKE JULIAN PAUL
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides amorphous forms and the crystalline complexes of SGLT2 inhibitors as a novel material in particular in pharmaceutically acceptable form. The crystalline forms of SGLT2 inhibitor canagliflozin are designated as Forms CS1 CS2 CS3 CS4 and CS5.